Published in J Physiol Pharmacol on September 01, 2007
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr Rev (2012) 1.11
Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production. J Physiol Pharmacol (2010) 1.03
The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol (2015) 0.81
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males. J Clin Invest (2017) 0.79
Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases. Mediators Inflamm (2017) 0.75
Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol (2003) 2.89
Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig. Prostaglandins (1975) 2.45
Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol (2006) 2.21
Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature (1978) 2.10
Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Kidney Int (2007) 1.80
Mouse models of experimental atherosclerosis. J Physiol Pharmacol (2004) 1.68
Prostacyclin is a circulating hormone. Nature (1978) 1.60
Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1990) 1.54
Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet (1978) 1.53
The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci (2010) 1.46
On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol (1987) 1.43
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol (2007) 1.42
Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene (2008) 1.40
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene (2007) 1.37
Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene (2010) 1.19
In vivo method for quantitation for anti-platelet potency of drugs. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.17
Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest (2005) 1.14
The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors. Br J Pharmacol (1990) 1.11
Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice. Eur J Clin Invest (2006) 1.09
Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J Physiol Pharmacol (2007) 1.08
Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol (2005) 1.06
Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol (2009) 1.05
Lipopolysaccharide increases release of a nitric oxide-like factor from endothelial cells. Eur J Pharmacol (1989) 1.04
Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy. Thromb Res (1978) 1.04
Surgical management of multiple bilateral fibroadenoma of the breast: the Ribeiro technique modified by Rezai. Anticancer Res (2009) 1.00
Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Br J Pharmacol (1990) 0.97
Selective inhibition of thromboxane A2 biosynthesis in blood platelets. Nature (1977) 0.95
[Evaluation of a cell block method in cytological diagnostics]. Pathologe (2012) 0.94
Effects of novel plant antioxidants on platelet superoxide production and aggregation in atherosclerosis. J Physiol Pharmacol (2006) 0.92
Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues. J Biol Inorg Chem (2010) 0.92
Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. Rofo (2011) 0.91
Endothelins release tissue plasminogen activator and prostanoids. Eur J Pharmacol (1990) 0.90
Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodilators. Lancet (1990) 0.89
Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis. Cell Mol Biol (Noisy-le-grand) (2007) 0.87
Fibrinolytic activity of 6-keto-prostaglandin E1. Thromb Haemost (1983) 0.87
The current view on the role of leukotrienes in atherogenesis. J Physiol Pharmacol (2010) 0.87
[Diagnosis and treatment of necrotizing fasciitis of the head and neck region]. Laryngorhinootologie (2000) 0.86
Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma. J Cancer Res Clin Oncol (2011) 0.86
Kaempferol, but not resveratrol inhibits angiotensin converting enzyme. J Physiol Pharmacol (2008) 0.86
The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice. J Physiol Pharmacol (2008) 0.86
Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart. Prostaglandins Leukot Essent Fatty Acids (2005) 0.85
Inhibition of nuclear factor-kappaB attenuates artherosclerosis in apoE/LDLR - double knockout mice. J Physiol Pharmacol (2005) 0.85
Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis. Ann Rheum Dis (2009) 0.84
Superoxide dismutase activity and expression in human venous and arterial bypass graft vessels. J Physiol Pharmacol (2005) 0.84
Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells. J Physiol Pharmacol (2002) 0.84
Placental Schistosoma haematobium infection in a German returnee from Malawi. Infection (2014) 0.84
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice. J Physiol Pharmacol (2012) 0.83
Respiratory movements alter the generation of prostacyclin and thromboxane A2 in isolated rat lungs: the influence of arachidonic acid-pathway inhibitors on the ratio between pulmonary prostacyclin and thromboxane A2. Prostaglandins (1981) 0.83
Thrombolytic action of ticlopidine: possible mechanisms. Eur J Pharmacol (1996) 0.83
Angiotensinogen metabolism in rat aorta: robust formation of proangiotensin-12. J Physiol Pharmacol (2010) 0.82
Thienopyridines: effects on cultured endothelial cells. J Physiol Pharmacol (1999) 0.82
Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol (2014) 0.82
Solitons as the early stage of quasicondensate formation during evaporative cooling. Phys Rev Lett (2011) 0.82
Treatment of endometriosis of uterosacral ligament and rectum through the vagina: description of a modified technique. Hum Reprod (2009) 0.82
Venous coupler for free-flap anastomosis. Anticancer Res (2009) 0.81
Interaction between NO donors and iloprost in human vascular smooth muscle, platelets, and leukocytes. J Cardiovasc Pharmacol (1989) 0.81
Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro. J Physiol Pharmacol (1999) 0.81
Production of prostacyclin and prostaglandin E2 in resting and IL-1beta-stimulated A549, HUVEC and hybrid EA.HY 926 cells. J Physiol Pharmacol (2006) 0.81
Third-stage nematode larvae of Contracaecum osculatum from Baltic cod (Gadus morhua) elicit eosinophilic granulomatous reactions when penetrating the stomach mucosa of pigs. Parasitol Res (2015) 0.81
Lungs as a generator of prostacyclin--hypothesis on physiological significance. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.80
AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice. J Physiol Pharmacol (2010) 0.80
Endothelial secretogogues and deformability of erythrocytes. J Physiol Pharmacol (2002) 0.80
S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.80
Interaction between stimulators of adenylate and guanylate cyclases in human leukocytes, platelets and arteries. Int J Tissue React (1989) 0.80
Prostacyclin therapy in peripheral arterial disease. Thromb Res (1981) 0.79
The effect of nebivolol on atherogenesis in apoE-knockout mice. J Physiol Pharmacol (2009) 0.79
Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography - electrospray ionization - mass spectrometry (LC-ESI-MS). J Physiol Pharmacol (2007) 0.79
Characterisation of Atherogenic Effects of Low Carbohydrate, High Protein Diet (LCHP) in ApoE/LDLR-/- Mice. J Nutr Health Aging (2015) 0.79
The role of nitric oxide in regulation of deformability of red blood cells in acute phase of endotoxaemia in rats. J Physiol Pharmacol (1997) 0.79
NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions. J Physiol Pharmacol (2008) 0.79
A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation. Acta Biol Med Ger (1978) 0.79
Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease. Wien Klin Wochenschr (1996) 0.79
Downsizing a tumor thrombus of advanced renal cell carcinoma with neoadjuvant systemic therapy and resulting histopathological effects. Urol Int (2010) 0.78
Influence of pre-operative ketoprofen administration (preemptive analgesia) on analgesic requirement and the level of prostaglandins in the early postoperative period. Pol J Pharmacol (2004) 0.78
Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors. Ann Oncol (2008) 0.78
The current view on biological potency of cationically modified chitosan. J Physiol Pharmacol (2014) 0.78
Release of a prostaglandin E-like substance into mixed venous blood during endotoxin hypotension in cats. Pol J Pharmacol Pharm (1975) 0.78
Effects of margarine supplemented with t10c12 and C9T11 CLA on atherosclerosis and steatosis in apoE/LDLR -/- mice. J Nutr Health Aging (2012) 0.78
Effect of L-arginine on plasminogen-activator inhibitor in hypertensive patients with hypercholesterolemia. N Engl J Med (1993) 0.78
beta-Pyridylcarbinol (Ronicol) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans. Pharmacol Res Commun (1983) 0.78
Transarterial catheter embolization of a sarcoma for preoperative conditioning. Vasa (2010) 0.78
Potential of MR mammography to predict tumor grading of invasive breast cancer. Rofo (2011) 0.77